Technical Analysis for PTGX - Protagonist Therapeutics, Inc.

Grade Last Price % Change Price Change
A 47.02 0.43% 0.20
PTGX closed up 0.43 percent on Friday, July 23, 2021, on 74 percent of normal volume.
Earnings due: Aug 4
*** please verify all earnings dates ***

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical PTGX trend table...

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Overbought Stochastic Strength 0.00%
Bollinger Band Squeeze Range Contraction 0.43%
NR7 Range Contraction 0.43%
Overbought Stochastic Strength 0.43%
Bollinger Band Squeeze Range Contraction -1.96%
New 52 Week High Strength -1.96%
Stochastic Reached Overbought Strength -1.96%
Upper Bollinger Band Walk Strength -1.96%
Older End-of-Day Signals for PTGX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
10 DMA Support 3 days ago
20 DMA Support 3 days ago
Down 2 % 3 days ago
Down 1% 3 days ago
Fell Below 10 DMA 3 days ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The Company's initial lead product candidates consists of PTG-100 and PTG-200, which have the potential to transform the existing treatment paradigm for inflammatory bowel disease, a GI disease consisting primarily of ulcerative colitis and Crohn's disease; PTG-300, an injectable hepcidin mimetic. Protagonist Therapeutics, Inc. is based in Milpitas, United States.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Immunology Autoimmune Diseases Proprietary Technology Inflammatory Bowel Disease Ulcer Colitis Ulcerative Colitis Abdominal Pain Crohn's Disease EPC Chemical Entities Epci Gi Disease Hepcidin

Is PTGX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 48.7
52 Week Low 14.16
Average Volume 446,752
200-Day Moving Average 28.28
50-Day Moving Average 40.21
20-Day Moving Average 45.79
10-Day Moving Average 46.43
Average True Range 1.96
ADX 29.51
+DI 25.36
-DI 18.53
Chandelier Exit (Long, 3 ATRs) 42.81
Chandelier Exit (Short, 3 ATRs) 48.08
Upper Bollinger Bands 48.37
Lower Bollinger Band 43.22
Percent B (%b) 0.74
BandWidth 11.24
MACD Line 1.93
MACD Signal Line 2.15
MACD Histogram -0.228
Fundamentals Value
Market Cap 1.8 Billion
Num Shares 38.3 Million
EPS -2.74
Price-to-Earnings (P/E) Ratio -17.15
Price-to-Sales 26.02
Price-to-Book 4.80
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 50.52
Resistance 3 (R3) 50.42 49.15 49.94
Resistance 2 (R2) 49.15 48.26 49.20 49.74
Resistance 1 (R1) 48.09 47.71 47.45 48.19 49.55
Pivot Point 46.82 46.82 46.50 46.87 46.82
Support 1 (S1) 45.75 45.93 45.12 45.85 44.49
Support 2 (S2) 44.48 45.38 44.53 44.30
Support 3 (S3) 43.42 44.48 44.10
Support 4 (S4) 43.52